Thomas L. Kempner, Director, 10% Owner at IGENE BIOTECHNOLOGY INC (IGNE), bought 100,000 shares at $0.03 ($3K) on 2006-12-19, disclosed to the SEC on 2006-12-22.
Open-market purchase of $3k IGNE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| DYAX | SELL | 2015-08-31 | $428K | — | Filing → |
| DYAX | SELL | 2015-08-19 | $430K | — | Filing → |
| DYAX | SELL | 2015-08-14 | $115K | — | Filing → |